Disclosure Of Interests In Other Entities [Text Block]

Isofol Medical - Filing #689617

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	209 451 SEK	—	—	—	—	394 609 SEK	—	—	—	—	—
Non-current assets	4 013 SEK	—	—	—	—	6 755 SEK	—	—	—	—	—
Current liabilities	51 735 SEK	—	—	—	—	83 020 SEK	—	—	—	—	—
Non-current liabilities	3 250 SEK	—	—	—	—	110,000 SEK	—	—	—	—	—
Revenue	—	—	12 797 SEK	—	—	—	—	—	22 407 SEK	—	—
Profit (loss)	—	- SEK	159 755 SEK	- SEK	159 755 SEK	—	- SEK	- SEK	200 251 SEK	200 251 SEK	—
Comprehensive income	—	- SEK	159 755 SEK	- SEK	159 755 SEK	—	- SEK	- SEK	200 251 SEK	200 251 SEK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	—	- SEK	- SEK	- SEK	- SEK	—	- SEK	- SEK	- SEK	- SEK	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	190 583 SEK	—	—	—	—	379 448 SEK	—	—	—	—	116 393 SEK
Depreciation and amortisation expense	—	—	1 642 SEK	—	—	—	—	—	1 596 SEK	—	—
Tax expense (income)	—	—	- SEK	—	—	—	—	—	- SEK	—	—